null
ChEBI ID: 36393
| Member | Definition | Role |
|---|---|---|
| 1,4-thiomorpholine-3,5-dicarboxylic acid | thiomorpholine-3,5-dicarboxylic acid | |
| prinomastat | A hydroxamic acid that is (3S)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide in which the hydrogen attached to the thiomorpholine nitrogen has been replaced by a [4-(pyridin-4-yloxy)phenyl]sulfonyl group. It is a selective inhibitor with of matrix metalloproteinases (MMPs) 2, 3, 9, 13, and 14. | prinomastat |
| thiamorpholine | A saturated organic heteromonocyclic parent that is an analogue of morpholine where the oxygen atom is replaced by sulfur. | thiomorpholine |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (4.41) | 18.7374 |
| 1990's | 12 (8.82) | 18.2507 |
| 2000's | 67 (49.26) | 29.6817 |
| 2010's | 33 (24.26) | 24.3611 |
| 2020's | 18 (13.24) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 5 (3.55%) | 5.53% |
| Reviews | 15 (10.64%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 121 (85.82%) | 84.16% |